LogicBio Therapeutics, Inc. Depreciation
LogicBio Therapeutics, Inc. reported Depreciation of $626.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-04.
Discontinued › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2022-03-04
- LogicBio Therapeutics, Inc. depreciation for the quarter ending 2018-12-31 was $40.00K, a 207.69% increase year-over-year.
- LogicBio Therapeutics, Inc. depreciation for the quarter ending 2017-12-31 was $13.00K.
- LogicBio Therapeutics, Inc. depreciation for fiscal 2021 was $626.00K, a 31.79% increase from fiscal 2020.
- LogicBio Therapeutics, Inc. depreciation for fiscal 2020 was $475.00K, a 64.36% increase from fiscal 2019.
- LogicBio Therapeutics, Inc. depreciation for fiscal 2019 was $289.00K, a 224.72% increase from fiscal 2018.
- LogicBio Therapeutics, Inc. depreciation for fiscal 2018 was $89.00K, a 106.98% increase from fiscal 2017.
| Period end | Depreciation 3 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|
| 2021-12-31 | $626.00K 10-K · filed 2022-03-04 | ||
| 2020-12-31 | $475.00K 10-K · filed 2022-03-04 | ||
| 2019-12-31 | $289.00K 10-K · filed 2021-03-15 | ||
| 2018-12-31 | $40.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $89.00K 10-K · filed 2020-03-16 | |
| 2018-09-30 | $49.00K 10-Q · filed 2018-12-03 | ||
| 2017-12-31 | $13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $43.00K 10-K · filed 2019-04-01 | |
| 2017-09-30 | $30.00K 10-Q · filed 2018-12-03 |